Giant Biogene Holding Co., Ltd.
2367
Rang in aandelen
#5026
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Aandeelprijs
$2.67
Marktkapitalisatie
$2.84B
Verandering (1 dag)
-6.09%
Verandering (1 jaar)
-46.20%
Land
CN
Handel Giant Biogene Holding Co., Ltd. (2367)
Categorie
Consumer Defensive
Winst voor Giant Biogene Holding Co., Ltd. (2367)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Giant Biogene Holding Co., Ltd. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Giant Biogene Holding Co., Ltd. van 2019 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2025 | $335.93M | -0.23% |
| 2024 | $336.72M | 36.58% |
| 2023 | $246.53M | 44.39% |
| 2022 | $170.74M | 11.54% |
| 2021 | $153.07M | 2.75% |
| 2020 | $148.98M | 53.23% |
| 2019 | $97.22M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $20.38B | - |
US
|
|
| $9.83B | - |
FR
|
|
| $2.94B | - |
US
|
|
| $1.55B | - |
IN
|
|
| $517.00M | - |
US
|
